Announcement
06 Jun 2021
In July 2021, the U.S. Administration announced its decision to procure Merck’s investigational antiviral medicine for COVID-19 treatment.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
07 Jun 2021
Revocation date:
No revocation date
Announced: 06 Jun 2021
Public procurement, nes
In force
On 7 June 2021, the U.S. Administration announced that the government will procure 1.7 million courses of Merck’s investigational antiviral treatment, molnupiravir (MK-4482) for USD 1.2 billion should...
Sign in to see more
Threads
See all
Harmful Trade Policy Measures
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70831
interventions
194
jurisdictions
Harmful Trade Policy Interventions: Medical Goods
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7365
interventions
152
jurisdictions
G7: Harmful Trade Policy Interventions
This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 13 Jan 2025
25583
interventions
38
jurisdictions
G20: Harmful Trade Policy Interventions
This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 15 Jan 2025
54115
interventions
121
jurisdictions